Cell Biotech Co., Ltd. (KOSDAQ:049960)
12,950
+110 (0.86%)
At close: Aug 28, 2025
Cell Biotech Market Cap
Cell Biotech has a market cap or net worth of 88.63 billion as of August 28, 2025. Its market cap has decreased by -8.16% in one year.
Market Cap
88.63B
Enterprise Value
3.26B
Revenue
47.46B
Ranking
n/a
PE Ratio
8.77
Stock Price
12,950.00
Market Cap Chart
Since March 3, 2003, Cell Biotech's market cap has increased from 13.97B to 88.63B, an increase of 534.51%. That is a compound annual growth rate of 8.56%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 28, 2025 | 88.63B | -9.25% |
Dec 30, 2024 | 97.66B | 27.18% |
Dec 28, 2023 | 76.79B | -11.65% |
Dec 29, 2022 | 86.92B | -34.80% |
Dec 30, 2021 | 133.30B | -19.84% |
Dec 30, 2020 | 166.29B | 21.02% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 459.67T |
SK hynix | 180.54T |
LG Energy Solution | 89.15T |
Samsung Biologics | 72.53T |
Hyundai Motor Company | 47.74T |
Hanwha Aerospace | 46.30T |
HD Hyundai Heavy Industries | 41.55T |
Doosan Enerbility | 40.54T |